<!DOCTYPE html lang="EN">
<html>

<head>
    <meta content="text/html; charset=UTF-8" http-equiv="Content-Type" />
    <title>ENAS6239</title>
    <meta content="width=device-width, initial-scale=1.0, maximum-scale=1.5, user-scalable=1" name="viewport" />
    <link charset="UTF-8" href="ENAS6239.css" rel="STYLESHEET" type="text/css" />
    <!-- <link charset="UTF-8" href="HighLight.css" rel="STYLESHEET" type="text/css" /> -->
    <script src="jquery-2.0.31.min.js"></script>
    <script type="text/javascript" src="HighlightSearch.js"></script>
    <link href="Single_Page_View.css" rel="stylesheet" type="text/css">
    <script src="jquery-3.4.1.min.js"></script>
    <script type="text/javascript" src="Single_Page_View.js"></script>
</head>

<body onload="calculate_white_space();" onscroll="initialise();">
    <div class="content_div">
        <div class="header1" id="ENAS6239_1.0.0.0"><span class="headers_span">Who should be tested for CD?</span></div>



        <p class="h1">Who should be test­ed for CD?</p>
        <table class="recomm-table">
            <colgroup>
                <col width="60%">
                <col width="20%">
                <col width="20%">
            </colgroup>
            <tbody>
                <tr>
                    <th class="table-header1">
                        <p class="table-title1">Rec­om­men­da­tions</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">COR</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">LOE</p>
                    </th>
                </tr>


                <tr>
                    <td>
                        <p class="table-text">Adult pa­tients with symp­toms, signs or lab­o­ra­to­ry ev­i­dence sug­ges­tive of mal­ab­sorp­tion should be test­ed with serol­o­gy for CD.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                        </p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">Screen­ing of asymp­tomat­ic ﬁrst-​de­gree fam­i­ly mem­ber of CD pa­tient is rec­om­mend­ed. If avail­able, HLA-​typ­ing may be oﬀered as the ﬁrst-​line test; if neg­a­tive, no fur­ther work-​up is need­ed.</p>
                    </td>
                    <td>
                        <p class="table-text">Con­di­tion­al rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">CD should be ex­clud­ed in pa­tients with un­ex­plained el­e­va­tion of serum amino­trans­ferase lev­els.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">T1DM should be screened reg­u­lar­ly for CD.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence</p>
                    </td>
                </tr>
            </tbody>
        </table>
    </div>
    <div class="content_div">
        <div class="header1" id="ENAS6239_2.0.0.0"><span class="headers_span">Role of serology in CD diagnosis</span>
        </div>


        <p class="h1">Role of serol­o­gy in CD di­ag­no­sis</p>
        <table class="recomm-table">
            <colgroup>
                <col width="60%">
                <col width="20%">
                <col width="20%">
            </colgroup>
            <tbody>
                <tr>
                    <th class="table-header1">
                        <p class="table-title1">Rec­om­men­da­tions</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">COR</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">LOE</p>
                    </th>
                </tr>


                <tr>
                    <td>
                        <p class="table-text">IgA-​TG2 an­ti­body is the pre­ferred sin­gle test for de­tec­tion of CD at any age.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">To­tal IgA lev­el needs to be mea­sured con­cur­rent­ly with serol­o­gy test­ing to de­ter­mine whether IgA lev­els are suﬃcient.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">In pa­tients with se­lec­tive to­tal IgA-​deﬁcien­cy, IgG-​ based test­ing (IgG-​DGPs or IgG-​TG2) should be per­formed at di­ag­no­sis and fol­low-​up.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">All di­ag­nos­tic sero­log­ic test­ing should be done while pa­tients on a gluten-​con­tain­ing diet.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">An­ti­bod­ies di­rect­ed against na­tive gliadin (AGA) are not rec­om­mend­ed for the pri­ma­ry de­tec­tion of CD.
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence</p>
                    </td>
                </tr>
            </tbody>
        </table>
    </div>
    <div class="content_div">
        <div class="header1" id="ENAS6239_3.0.0.0"><span class="headers_span">Endoscopy and histopathology</span></div>


        <p class="h1">En­doscopy and histopathol­o­gy</p>
        <table class="recomm-table">
            <colgroup>
                <col width="60%">
                <col width="20%">
                <col width="20%">
            </colgroup>
            <tbody>
                <tr>
                    <th class="table-header1">
                        <p class="table-title1">Rec­om­men­da­tions</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">COR</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">LOE</p>
                    </th>
                </tr>


                <tr>
                    <td>
                        <p class="table-text">When CD is sus­pect­ed biop­sies, should be tak­en even when the en­do­scop­ic ap­pear­ance of the duo­de­num is nor­mal.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">Duo­de­nal biop­sy is an es­sen­tial com­po­nent of the di­ag­nos­tic eval­u­a­tion for adults with sus­pect­ed CD and is rec­om­mend­ed to conﬁrm the di­ag­no­sis.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">Mul­ti­ple biop­sies of the duo­de­num (at least four of the sec­ond part of duo­de­num) are rec­om­mend­ed to conﬁrm the di­ag­no­sis of CD.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">The ad­di­tion of two biop­sies of the duo­de­nal bulb might in­crease the di­ag­nos­tic yield.</p>
                    </td>
                    <td>
                        <p class="table-text">Con­di­tion­al rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text"> low lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">An in­crease in IEL inﬁltra­tion in the ab­sence of VA in duo­de­nal biop­sies (Marsh 1) is not speciﬁc for CD and oth­er caus­es should be ex­clud­ed.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence</p>
                    </td>
                </tr>


                <tr>
                    <td>
                        <p class="table-text"><span class="italic">H. py­lori </span>in­fec­tion is fre­quent­ly as­so­ci­at­ed with Marsh 1 his­tol­o­gy and its erad­i­ca­tion may lead to nor­mal­iza­tion of duo­de­nal IEL count. Con­comi­tant gas­tric biop­sies or per­form­ing
                            serol­o­gy is need­ed when H. py­lori is sus­pect­ed.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">If CD is high­ly sus­pect­ed, duo­de­nal biop­sy should be done even if serol­o­gy is neg­a­tive.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>


                </tr>


            </tbody>
        </table>
    </div>
    <div class="content_div">
        <div class="header1" id="ENAS6239_4.0.0.0"><span class="headers_span">HLA-DQ2/8 Typing in CD diagnosis</span>
        </div>


        <p class="h1">HLA-​DQ2/​8 Typ­ing in CD di­ag­no­sis</p>
        <table class="recomm-table">
            <colgroup>
                <col width="60%">
                <col width="20%">
                <col width="20%">
            </colgroup>
            <tbody>
                <tr>
                    <th class="table-header1">
                        <p class="table-title1">Rec­om­men­da­tions</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">COR</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">LOE</p>
                    </th>
                </tr>
                <tr>
                    <td colspan="3">
                        <p class="table-text"><span class="bold">HLA-​DQ2/​8 Typ­ing in CD di­ag­no­sis:</span></p>
                    </td>
                </tr>


                <tr>
                    <td>
                        <p class="table-text">HLA-​DQ2/​DQ8 test­ing should not be used rou­tine­ly in the ini­tial di­ag­no­sis of CD. It is rec­om­mend­ed that the re­sults of such test­ing should be in­clud­ed along with a cau­tion that pa­tients at risk should be sero­log­i­cal­ly
                            test­ed for CD with­out chang­ing their diet.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">HLA-​DQ2/​DQ8 test­ing should be used to rule out CD in se­lect­ed clin­i­cal sit­u­a­tions, in­clud­ing:</p>

                        <p class="listlevel2">Marsh 1–2 his­tol­o­gy in seroneg­a­tive pa­tients;</p>


                        <p class="listlevel2">Eval­u­a­tion of pa­tients in whom no test­ing for CD was done be­fore be­ing start­ed on GFD;</p>

                        <p class="listlevel2">When the re­sults of coeli­ac-​speciﬁc serol­o­gy and his­tol­o­gy are dis­crepant.
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>
            </tbody>
        </table>
    </div>
    <div class="content_div">
        <div class="header1" id="ENAS6239_5.0.0.0"><span class="headers_span">Other tests in CD diagnosis</span></div>


        <p class="h1">Oth­er tests in CD di­ag­no­sis</p>
        <table class="recomm-table">
            <colgroup>
                <col width="60%">
                <col width="20%">
                <col width="20%">
            </colgroup>
            <tbody>
                <tr>
                    <th class="table-header1">
                        <p class="table-title1">Rec­om­men­da­tions</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">COR</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">LOE</p>
                    </th>
                </tr>

                <tr>
                    <td colspan="3">
                        <p class="table-text"><span class="bold">Oth­er tests in CD di­ag­no­sis:</span></p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">VCE is not used for ini­tial di­ag­no­sis of CD ex­cept for pa­tients with pos­i­tive coeli­ac-​speciﬁc serol­o­gy who are un­will­ing or un­able to un­der­go en­doscopy with biop­sy.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">VCE is im­por­tant in de­tect­ing com­pli­ca­tions as­so­ci­at­ed with CD.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">In­testi­nal-​per­me­abil­i­ty tests are nei­ther sen­si­tive nor speciﬁc and are not rec­om­mend­ed for CD di­ag­no­sis.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">Serum I-​FABP might be use­ful in iden­ti­fy­ing di­etary non-​ad­her­ence and un­in­ten­tion­al gluten in­take.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence
                        </p>
                    </td>
                </tr>
                </td>
                </tr>
            </tbody>
        </table>
    </div>
    <div class="content_div">
        <div class="header1" id="ENAS6239_6.0.0.0"><span class="headers_span">Establishing a diagnosis of CD</span>
        </div>


        <p class="h1">Es­tab­lish­ing a di­ag­no­sis of CD</p>
        <table class="recomm-table">
            <colgroup>
                <col width="60%">
                <col width="20%">
                <col width="20%">
            </colgroup>
            <tbody>
                <tr>
                    <th class="table-header1">
                        <p class="table-title1">Rec­om­men­da­tions</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">COR</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">LOE</p>
                    </th>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">The conﬁrma­tion of a CD di­ag­no­sis should be based on clin­i­cal data, pos­i­tive serol­o­gy and duo­de­nal his­tol­o­gy.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">Im­prove­ment of symp­toms or ex­ac­er­ba­tion af­ter re-​in­tro­duc­tion of gluten has a very low pre­dic­tive val­ue for CD and should not be used for di­ag­no­sis in the ab­sence of oth­er sup­port­ive ev­i­dence.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence
                        </p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">A pos­i­tive CD-​speciﬁc serol­o­gy in pa­tients with VA conﬁrms the di­ag­no­sis of CD.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence
                        </p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">In asymp­tomat­ic pa­tients with pos­i­tive (but low titre) coeli­ac serol­o­gy, the de­ci­sion to per­form biop­sy may be pre­ced­ed by re­peat­ing serol­o­gy test at 3–6 months.</p>
                    </td>
                    <td>
                        <p class="table-text">Con­di­tion­al rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">low lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">In case of el­e­vat­ed TG2-​titre and nor­mal his­tol­o­gy: biop­sies should be re­viewed by a pathol­o­gist fa­mil­iar with CD. It is rec­om­mend­ed to re­peat biop­sy af­ter gluten chal­lenge if the pa­tient was not on gluten-​con­tain­ing
                            diet be­fore test­ing. HLA-​DQ2/​8 typ­ing is manda­to­ry. Test­ing for oth­er an­ti­bod­ies, e.g. DGP and/​or EMA, may be of added val­ue.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">Strong­mod­er­ate lev­el of ev­i­dence
                        </p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">In symp­tomat­ic pa­tients and/​or ab­nor­mal lab­o­ra-​ tory tests with Marsh 1: If both anti-​TG2 and EMA are pos­i­tive then CD is like­ly; If EMA is neg­a­tive, then the ab­sence of HLA-​DQ2/​8 ex­cludes CD; while in the pres­ence
                            of HLA-​ DQ2/​8, it is ad­vis­able to re­peat serol­o­gy af­ter 6–12 months.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Con­di­tion­al rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">low lev­el of ev­i­dence
                        </p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">Seroneg­a­tive CD re­quires care­ful as­sess­ment with HLA-​DQ2/​8 test­ing and a re­sponse to a GFD af­ter ex­clud­ing oth­er caus­es of seroneg­a­tive VA. Coeli­ac serol­o­gy, both IgA-​ and IgG-​based, should be neg­a­tive.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion
                        </p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text"> In pa­tients who are al­ready fol­low­ing GFD pri­or to test­ing, serol­o­gy and HLA typ­ing are need­ed. If serol­o­gy is pos­i­tive, then biop­sy is the next step. Gluten chal­lenge should be un­der­tak­en when serol­o­gy is
                            neg­a­tive but HLA DQ2/​DQ8 pos­i­tive.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence
                        </p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text"> In adults there are some data sug­gest­ing that the di­ag­no­sis of CD may be made with­out conﬁrma­to­ry biop­sy; how­ev­er, these data are cur­rent­ly un­der scruti­ny and need more conﬁrma­tion be­fore a ﬁrm rec­om­men­da­tion
                            can be made.</p>
                        <td>
                            <p class="table-text">-​</p>
                        </td>
                        <td>
                            <p class="table-text">-​</p>
                        </td>
                    </td>
                </tr>
            </tbody>
        </table>
    </div>
    <div class="content_div">
        <div class="header1" id="ENAS6239_7.0.0.0"><span class="headers_span">Dietary management</span></div>


        <p class="h1">Di­etary man­age­ment</p>
        <table class="recomm-table">
            <colgroup>
                <col width="60%">
                <col width="20%">
                <col width="20%">
            </colgroup>
            <tbody>
                <tr>
                    <th class="table-header1">
                        <p class="table-title1">Rec­om­men­da­tions</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">COR</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">LOE</p>
                    </th>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">Pa­tients with CD should ad­here to a life­long GFD.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion
                        </p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">Oats are safe­ly tol­er­at­ed by the ma­jor­i­ty of CD pa­tients; its in­tro­duc­tion into the diet should be cau­tious and pa­tients should be mon­i­tored for pos­si­ble ad­verse re­ac­tion.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">Pa­tients with CD should be re­ferred to a di­eti­tian who is well-​trained con­cern­ing CD in or­der to get a de­tailed nu­tri­tion­al as­sess­ment, ed­u­ca­tion on the GFD and sub­se­quent mon­i­tor­ing.
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>

                        <tr>
                            <td>
                                <p class="table-text">A new­ly di­ag­nosed adult CD pa­tient should un­der­go test­ing to un­cov­er deﬁcien­cies of es­sen­tial mi­cronu­tri­ent, e.g. iron, folic acid, vi­ta­min D and vi­ta­min B12. </p>
                            </td>
                            <td>
                                <p class="table-text">Strong rec­om­men­da­tion</p>
                            </td>
                            <td>
                                <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                            </td>
                        </tr>

                        <tr>
                            <td>
                                <p class="table-text">Pa­tients should be ad­vised to eat a high-​ﬁbre diet sup­ple­ment­ed with whole-​grain rice, maize, pota-​ toes and am­ple veg­eta­bles.</p>
                            </td>
                            <td>
                                <p class="table-text">Strong rec­om­men­da­tion</p>
                            </td>
                            <td>
                                <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                            </td>
                        </tr>
                    </td>
                </tr>
            </tbody>
        </table>
    </div>
    <div class="content_div">
        <div class="header1" id="ENAS6239_8.0.0.0"><span class="headers_span">Follow-up CD in adult</span></div>


        <p class="h1">Fol­low-​up CD in adult</p>
        <table class="recomm-table">
            <colgroup>
                <col width="60%">
                <col width="20%">
                <col width="20%">
            </colgroup>
            <tbody>
                <tr>
                    <th class="table-header1">
                        <p class="table-title1">Rec­om­men­da­tions</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">COR</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">LOE</p>
                    </th>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">CD pa­tients should be mon­i­tored reg­u­lar­ly for per­sis­tent or new symp­toms, ad­her­ence to GFD and as­sess­ment for com­pli­ca­tions.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence
                        </p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">Pe­ri­od­ic med­i­cal fol­low-​up should be per­formed by a gas­troen­terol­o­gist or physi­cian with spe­cial ex­per­tise in CD.</p>
                    </td>
                    <td>
                        <p class="table-text">Mod­er­ate rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">low lev­el of ev­i­dence
                        </p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">Di­etary re­vi­sion should be per­formed by a di­eti­tian with spe­cial ex­per­tise in CD es­pe­cial­ly in slow-​re­spon­ders to ex­clude gluten con­tam­i­na­tion.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">Mon­i­tor­ing of ad­her­ence to GFD should be based on a com­bi­na­tion of his­to­ry and serol­o­gy.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">A nor­mal anti-​TG2 lev­el at fol­low-​up does not pre­dict re­cov­ery of VA.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">-​</p>
                    </td>
                    <td>
                        <p class="table-text">-​</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">A fol­low-​up duo­de­nal biop­sy is rec­om­mend­ed for mon­i­tor­ing in cas­es of lack of clin­i­cal re­sponse or re­lapse of symp­toms de­spite a GFD.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence
                        </p>
                    </td>
                </tr>


                <tr>
                    <td>
                        <p class="table-text">Mon­i­tor­ing of coeli­acs should in­clude veriﬁcation of nor­mal­iza­tion of lab­o­ra­to­ry ab­nor­mal­i­ties de­tect­ed dur­ing ini­tial in­ves­ti­ga­tion.</p>

                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion
                        </p>

                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">It is ad­vis­able to fol­low-​up at-​risk fam­i­ly mem­bers with serol­o­gy. Those who have pos­i­tive serol­o­gy or de­vel­op symp­toms should have duo­de­nal biop­sy ex­am­i­na­tion.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Con­di­tion­al rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">low lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">CD pa­tients who are known to be hy­pos­plenic should re­ceive the pneu­mo­coc­cal vac­cine.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>

                <tr>
                    <td>
                        <p class="table-text">DEXA should be mea­sured in those at high risk of os­teo­poro­sis. It may be per­formed at di­ag­no­sis es­pe­cial­ly in those with mal­ab­sorp­tion or those at high risk if there is a long de­lay in di­ag­no­sis or there are clin­i­cal
                            pre­sen­ta­tions sug­ges­tive of bone dis­ease. In oth­ers, not lat­er than age of 30–35 years and then to be re­peat­ed at 5-​year in­ter­vals. A short­er in­ter­val (2–3 years) is need­ed in case of low bone den­si­ty on
                            in­dex mea­sure­ment, ev­i­dence of on­go­ing VA or poor di­etary ad­her­ence.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>


            </tbody>
        </table>
    </div>
    <div class="content_div">
        <div class="header1" id="ENAS6239_9.0.0.0"><span class="headers_span">Slow-responders and refractory CD</span>
        </div>



        <p class="h1">Slow-​re&shy;spon&shy;ders and re&shy;frac&shy;to&shy;ry CD</p>

        <table class="recomm-table">
            <colgroup>
                <col width="60%" />
                <col width="20%" />
                <col width="20%" />
            </colgroup>
            <tbody>
                <tr>
                    <th class="table-header1">
                        <p class="table-title1">Rec&shy;om&shy;men&shy;da&shy;tions</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">COR</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">LOE</p>
                    </th>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">Pa&shy;tients show&shy;ing slow re&shy;sponse should be eval&shy;u&shy;at&shy;ed care&shy;ful&shy;ly to ex&shy;clude di&shy;etary in&shy;con&shy;sis&shy;ten&shy;cies and also iden&shy;ti&shy;fy oth&shy;er speciﬁc ae&shy;ti&shy;olo&shy;gies.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">Eval&shy;u&shy;a&shy;tion of slow-​re&shy;spon&shy;ders should in&shy;clude re&shy;view ini&shy;tial di&shy;ag&shy;no&shy;sis, coeli&shy;ac serol&shy;o&shy;gy, a di&shy;etary re&shy;view and fol&shy;low-​up duo&shy;de&shy;nal biop&shy;sy.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">Dis&shy;tinc&shy;tion should be made be&shy;tween RCD-​I and RCD-​II to se&shy;lect ap&shy;pro&shy;pri&shy;ate man&shy;age&shy;ment and de&shy;ter&shy;mine the prog&shy;no&shy;sis.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod&shy;er&shy;ate lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">T-​cell ﬂow cy&shy;tom&shy;e&shy;try is the most re&shy;li&shy;able method to make a dis&shy;tinc&shy;tion be&shy;tween RCD-​I and RCD-​II.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod&shy;er&shy;ate lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">The nu&shy;tri&shy;tion&shy;al sta&shy;tus of RCD pa&shy;tients should be mon&shy;i&shy;tored close&shy;ly. Nu&shy;tri&shy;tion&shy;al sup&shy;port in&shy;clud&shy;ing par&shy;enter&shy;al nu&shy;tri&shy;tion forms an es&shy;sen&shy;tial
                            part of the man&shy;age&shy;ment.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">EATL should be conﬁdent&shy;ly ex&shy;clud&shy;ed be&shy;fore start&shy;ing treat&shy;ment with med&shy;i&shy;ca&shy;tions in RCD-​II.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod&shy;er&shy;ate lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">RCD-​II pa&shy;tients need to be treat&shy;ed in re&shy;fer&shy;ral cen&shy;tres by an ex&shy;pe&shy;ri&shy;enced gas&shy;troen&shy;terol&shy;o&shy;gist in CD in col&shy;lab&shy;o&shy;ra&shy;tion with haema&shy;tol&shy;o&shy;gist.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod&shy;er&shy;ate lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">EATL needs to be ex&shy;clud&shy;ed in any CD pa&shy;tient with ab&shy;dom&shy;i&shy;nal pain, fever, ob&shy;struc&shy;tion, anaemia, gas&shy;troin&shy;testi&shy;nal bleed&shy;ing or un&shy;ex&shy;plained weight loss.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod&shy;er&shy;ate lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">In EATL: de&shy;bulk&shy;ing surgery for large ul&shy;cer&shy;at&shy;ed small bow&shy;el tu&shy;mours is rec&shy;om&shy;mend&shy;ed for lim&shy;it&shy;ing the risk of per&shy;fo&shy;ra&shy;tion or bleed&shy;ing dur&shy;ing chemother&shy;a&shy;py.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod&shy;er&shy;ate lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
            </tbody>
        </table>


    </div>
    <div class="content_div">
        <div class="header1" id="ENAS6239_10.0.0.0"><span class="headers_span">Special issues concerning CD in childhood
                and adolescence</span></div>



        <p class="h1">Spe&shy;cial is&shy;sues con&shy;cern&shy;ing CD in child&shy;hood and ado&shy;les&shy;cence</p>

        <table class="recomm-table">
            <colgroup>
                <col width="60%" />
                <col width="20%" />
                <col width="20%" />
            </colgroup>
            <tbody>
                <tr>
                    <th class="table-header1">
                        <p class="table-title1">Rec&shy;om&shy;men&shy;da&shy;tions</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">COR</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">LOE</p>
                    </th>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">The conﬁrma&shy;tion of a CD di&shy;ag&shy;no&shy;sis in some chil&shy;dren should be based on a com&shy;bi&shy;na&shy;tion of clin&shy;i&shy;cal data, pos&shy;i&shy;tive serol&shy;o&shy;gy and duo&shy;de&shy;num biop&shy;sies.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod&shy;er&shy;ate lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">Duo&shy;de&shy;nal his&shy;tol&shy;o&shy;gy in some chil&shy;dren is rec&shy;om&shy;mend&shy;ed to conﬁrm the di&shy;ag&shy;no&shy;sis of CD.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">CD di&shy;ag&shy;no&shy;sis may be made with&shy;out duo&shy;de&shy;nal biop&shy;sy in symp&shy;tomat&shy;ic chil&shy;dren with high TG2 lev&shy;els (&gt;10 times ULN) and EMA in the pres&shy;ence of HLA-​DQ2/​8. The di&shy;ag&shy;no&shy;sis
                            is conﬁrmed by an an&shy;ti&shy;body de&shy;cline and prefer&shy;ably a clin&shy;i&shy;cal re&shy;sponse to a GFD.</p>
                    </td>
                    <td>
                        <p class="table-text">Con&shy;di&shy;tion&shy;al rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod&shy;er&shy;ate lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">Gluten chal&shy;lenge is in&shy;di&shy;cat&shy;ed when the CD di&shy;ag&shy;no&shy;sis in doubt with neg&shy;a&shy;tive serol&shy;o&shy;gy be&shy;fore start&shy;ing a GFD. It should not be per&shy;formed be&shy;fore the child is
                            5 years old or dur&shy;ing the pu&shy;ber&shy;tal growth spurt.</p>
                    </td>
                    <td>
                        <p class="table-text">Con&shy;di&shy;tion&shy;al rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod&shy;er&shy;ate lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">A GFD should be in&shy;tro&shy;duced only when CD di&shy;ag&shy;no&shy;sis has been made con&shy;clu&shy;sive&shy;ly.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">The du&shy;ra&shy;tion of breast feed&shy;ing and/​or gluten in&shy;tro&shy;duc&shy;tion while the in&shy;fant is still breast fed had no im&shy;pact on the risk of de&shy;vel&shy;op&shy;ing CD.</p>
                    </td>
                    <td>
                        <p class="table-text">Mod&shy;er&shy;ate rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod&shy;er&shy;ate lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">There is cur&shy;rent&shy;ly no ev&shy;i&shy;dence to rec&shy;om&shy;mend avoid&shy;ing ei&shy;ther an ear&shy;ly (at 4 months of age) or a late (at or af&shy;ter 6 or even 12 months) gluten in&shy;tro&shy;duc&shy;tion in chil&shy;dren
                            at risk of CD.</p>
                    </td>
                    <td>
                        <p class="table-text">Mod&shy;er&shy;ate rec&shy;om&shy;men&shy;da&shy;tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod&shy;er&shy;ate lev&shy;el of ev&shy;i&shy;dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">A grad&shy;u&shy;al trans&shy;fer of med&shy;i&shy;cal care of an ado&shy;les&shy;cent with CD to adult care is rec&shy;om&shy;mend&shy;ed. The trans&shy;fer should be struc&shy;tured and in&shy;clude as the min&shy;i&shy;mum writ&shy;ten
                            in&shy;for&shy;ma&shy;tion on the base of di&shy;ag&shy;no&shy;sis, fol&shy;low-​up, an&shy;thro&shy;po&shy;met&shy;ric data, co&shy;mor&shy;bidi&shy;ties and di&shy;etary ad&shy;her&shy;ence.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">-​</p>
                    </td>
                    <td>
                        <p class="table-text">-​</p>
                    </td>
                </tr>
            </tbody>
        </table>


    </div>
    <div class="content_div">
        <div class="header1" id="ENAS6239_11.0.0.0"><span class="headers_span">Non-coeliac gluten sensitivity</span>
        </div>


        <p class="h1">Non-​coeli­ac gluten sen­si­tiv­i­ty</p>
        <table class="recomm-table">
            <colgroup>
                <col width="60%">
                <col width="20%">
                <col width="20%">
            </colgroup>
            <tbody>
                <tr>
                    <th class="table-header1">
                        <p class="table-title1">Rec­om­men­da­tions</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">COR</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">LOE</p>
                    </th>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">NCGS may be con­sid­ered in pa­tients with gluten-​re­lat­ed in­testi­nal and/​or ex­tra-​in­testi­nal com­plaints show­ing a nor­mal re­sult of the CD and WA sero­log­i­cal mark­ers on a gluten-​con­tain­ing diet.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">Serol­o­gy and small-​bow­el his­tol­o­gy (while the pa­tient is on a gluten-​con­tain­ing diet) and HLA-​DQ typ­ing (to rule out CD if neg­a­tive) are need­ed to dif­fer­en­ti­ate be­tween CD and NCGS.
                        </p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">The di­ag­no­sis of NCGS is ex­clud­ed in sub­jects fail­ing to show symp­tomat­ic im­prove­ment af­ter 6 weeks of GFD.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">A less-​strin­gent GFD might be enough com­pared with those with CD.</p>
                    </td>
                    <td>
                        <p class="table-text">Con­di­tion­al rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">low lev­el of ev­i­dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">Pa­tients show­ing a neg­a­tive gluten chal­lenge should be in­ves­ti­gat­ed for oth­er pos­si­ble caus­es of IBS-​like symp­toms.</p>
                    </td>
                    <td>
                        <p class="table-text">Con­di­tion­al rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">low lev­el of ev­i­dence</p>
                    </td>
                </tr>


            </tbody>
        </table>
    </div>
    <div class="content_div">
        <div class="header1" id="ENAS6239_12.0.0.0"><span class="headers_span">CD-related skin and oro-dental
                disorders</span></div>


        <p class="h1">CD-​re­lat­ed skin and oro-​den­tal dis­or­ders</p>
        <table class="recomm-table">
            <colgroup>
                <col width="60%">
                <col width="20%">
                <col width="20%">
            </colgroup>
            <tbody>
                <tr>
                    <th class="table-header1">
                        <p class="table-title1">Rec­om­men­da­tions</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">COR</p>
                    </th>
                    <th class="table-header1">
                        <p class="table-title1">LOE</p>
                    </th>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">The di­ag­no­sis of DH should al­ways be conﬁrmed by DIF ex­am­i­na­tion of per­ile­sion­al skin show­ing gran­u­lar IgA de­posits in the pap­il­lary der­mis.</p>

                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence</p>
                    </td>
                </tr>
                <tr>
                    <td>
                        <p class="table-text">In case of typ­i­cal re­sults from DIF and pos­i­tive anti-​TG2, the di­ag­no­sis of DH and CD can be conﬁrmed.</p>
                    </td>
                    <td>
                        <p class="table-text">Strong rec­om­men­da­tion</p>
                    </td>
                    <td>
                        <p class="table-text">high lev­el of ev­i­dence
                        </p>
                        <tr>
                            <td>
                                <p class="table-text">If the pa­tient is on a GFD, a gluten-​con­tain­ing diet should be ad­min­is­tered and the biop­sy tak­en af­ter at least 1 month.</p>
                            </td>
                            <td>
                                <p class="table-text">Strong rec­om­men­da­tion</p>
                            </td>
                            <td>
                                <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                            </td>
                        </tr>
                        <tr>
                            <td>
                                <p class="table-text">GFD is es­sen­tial in the man­age­ment of DH.
                            </td>
                            <td>
                                <p class="table-text">Strong rec­om­men­da­tion</p>
                            </td>
                            <td>
                                <p class="table-text">high lev­el of ev­i­dence</p>
                            </td>
                        </tr>
                        <tr>
                            <td>
                                <p class="table-text">Dap­sone is con­sid­ered an es­sen­tial ther­a­peu­tic op­tion for pa­tients with DH dur­ing the 6–24-​ month pe­ri­od un­til the GFD is eﬀec­tive.</p>
                            </td>
                            <td>
                                <p class="table-text">Strong rec­om­men­da­tion</p>
                            </td>
                            <td>
                                <p class="table-text">mod­er­ate lev­el of ev­i­dence</p>
                            </td>
                        </tr>
                        <tr>
                            <td>
                                <p class="table-text">GFD should be con­sid­ered in pa­tient with pso­ri­a­sis and sero­log­i­cal ev­i­dence of glutenin­tol­er­ance even in the ab­sence of clin­i­cal signs of CD.</p>
                            </td>
                            <td>
                                <p class="table-text">Con­di­tion­al rec­om­men­da­tion
                                </p>
                            </td>
                            <td>
                                <p class="table-text">low lev­el of ev­i­dence</p>
                            </td>
                        </tr>
                    </td>
                </tr>
        </table>
    </div>
</body>